Accès à distance ? S'identifier sur le proxy UCLouvain
Use of alemtuzumab in B cell chronic lymphocytic leukaemia (CLL) : Belgian recommendations
Primary tabs
Document type | Article de périodique (Journal article) |
---|---|
Publication date | 2011 |
Language | Anglais |
Journal information | "Belgian Journal of Hematology" - Vol. 2, p. 64-69 (2011) |
Peer reviewed | yes |
Publisher | Ariez International B.V. |
issn | 2033-3749 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - (MGD) Service d'hématologie |
Links |
Bibliographic reference | Bron, Dominique ; Janssens, A. ; Vandebroek, I. ; Chatelain, Christian ; De Prijck, B. ; et. al. Use of alemtuzumab in B cell chronic lymphocytic leukaemia (CLL) : Belgian recommendations. In: Belgian Journal of Hematology, Vol. 2, p. 64-69 (2011) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/123967 |